Kusurinomadoguchi, Inc. (5592) Price & Analysis

Compare

0 Followers

5592 Stock Chart & Stats

¥2661.00

-¥9.00(-0.63%)

At close: Jan 08 4:00 PM EST

¥2661.00

-¥9.00(-0.63%)

Day’s Range― - ―

52-Week Range¥1,677.00 - ¥4,685.00

Previous CloseN/A

Volume47.70K

Average Volume (3M)73.92K

Market Cap

¥29.26B

Enterprise Value¥27.85B

Total Cash (Recent Filing)¥1.89B

Total Debt (Recent Filing)¥56.01M

Price to Earnings (P/E)11.1

Beta0.70

Next Earnings

May 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.03%

Share Statistics

EPS (TTM)44.36

Shares Outstanding11,360,482

10 Day Avg. Volume72,500

30 Day Avg. Volume73,916

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)2.65

Price to Sales (P/S)2.00

P/FCF Ratio-4.17

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

High Profit MarginsSustained high gross and operating margins point to strong pricing power and an efficient cost base in its retail pharmacy model. These margins support durable internal cash generation potential, reinvestment capacity, and resilience to moderate demand or input-cost shocks over the medium term.

Robust Equity Base And Minimal LeverageVery low financial leverage and a high equity ratio give the firm considerable financial flexibility to fund strategic investments, weather downturns, and maintain creditor confidence. A high ROE indicates effective equity use, supporting sustainable shareholder returns if earnings persist.

Strong Revenue GrowthMaterial top-line growth suggests successful market penetration and demand for pharmacy and consulting services, aided by structural drivers like Japan's aging population. Durable revenue expansion underpins scale benefits and margin sustainability if the company maintains execution.

Bears Say

Significant Negative Free Cash FlowLarge negative free cash flow signals the business is consuming cash despite accounting profits, constraining the company’s ability to self-fund capex, dividends, or strategic M&A. Over 2–6 months this increases reliance on financing and raises medium‑term liquidity risk.

Weak Cash Conversion From EarningsEarnings are not translating into operating cash, suggesting working-capital strain, timing mismatches, or one-time accounting gains. Persistent poor cash conversion undermines earnings quality and can force operational adjustments or external financing to sustain growth.

Drop In Cash And Short-term InvestmentsA meaningful decline in liquid reserves reduces the firm’s buffer against shocks despite low debt. This tightens short-term flexibility for inventory funding, store rollout, or unforeseen costs, and may necessitate precautionary measures that could slow strategic initiatives.

Kusurinomadoguchi, Inc. News

Kusurinomadoguchi, Inc. Reports Strong Q3 Financial Performance

Kusurinomadoguchi, Inc. ( ($JP:5592) ) has provided an announcement. Kusurinomadoguchi, Inc. reported a strong financial performance for the...

12M ago

5592

Kusurinomadoguchi Reports Strong Sales Growth and New Alliance

Kusurinomadoguchi, Inc. (JP:5592) has released an update. Kusurinomadoguchi, Inc. reported a 28% year-on-year increase in sales to 5.44...

1y ago

5592

5592 FAQ

What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?

Kusurinomadoguchi, Inc. lowest stock price was ¥1677.00 and its highest was ¥4685.00 in the past 12 months.

What is Kusurinomadoguchi, Inc.’s market cap?

Kusurinomadoguchi, Inc.’s market cap is ¥29.26B.

When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?

Kusurinomadoguchi, Inc.’s upcoming earnings report date is May 20, 2026 which is in 92 days.

How were Kusurinomadoguchi, Inc.’s earnings last quarter?

Kusurinomadoguchi, Inc. released its earnings results on Feb 13, 2026. The company reported ¥44.36 earnings per share for the quarter, beating the consensus estimate of N/A by ¥44.36.

Is Kusurinomadoguchi, Inc. overvalued?

According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kusurinomadoguchi, Inc. pay dividends?

Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 1.03%. See more information on Kusurinomadoguchi, Inc. dividends here

What is Kusurinomadoguchi, Inc.’s EPS estimate?

Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kusurinomadoguchi, Inc. have?

Kusurinomadoguchi, Inc. has 11,360,482 shares outstanding.

What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?

Kusurinomadoguchi, Inc. reported an EPS of ¥44.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.572%.

Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?

Currently, no hedge funds are holding shares in JP:5592

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kusurinomadoguchi, Inc.

Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.